PM Modi says all Indians will get coronavirus vaccine, expert group to monitor distribution through 28,000 cold chains

  • | Thursday | 29th October, 2020

New Delhi: Prime Minister Narendra Modi has said all Indians will be vaccinated with the coronavirus vaccine one it is available and no one will be left behind. PM Narendra Modi has also said that a national expert group has been created to manage vaccine administration and chart the path.

New Delhi: Prime Minister Narendra Modi has said all Indians will be vaccinated with the coronavirus vaccine one it is available and no one will be left behind. PM Narendra Modi has also said that a national expert group has been created to manage vaccine administration and chart the path.

Speaking to The Economic Times in an interview, Prime Minister Narendra Modi said, “I would like to assure the nation that, as and when a vaccine becomes available, everyone will be vaccinated. No one will be left behind.” PM Narendra Modi further added, “Of course, initially we may focus on protecting the most vulnerable and the frontline workers. A National Expert Group on Vaccine Administration for Covid-19 has been constituted to chart the way forward.”

Speaking on the massive exercise of taking the coronavirus vaccine to the entire population of India, PM Narendra Modi said, “On logistics, more than 28,000 cold chain points will store and distribute Covid-19 vaccines to ensure they reach the last point. Dedicated teams at state, district and local levels will see to it that vaccine distribution and administration is done in a systematic and accountable manner.” However, Prime Minister Narendra Modi added that coronavirus vaccine is still a work in progress and trials are on. PM Modi also said that experts will guide the administration on how to approach the distribution of coronavirus vaccine among citizens.

Globally, around 150 coronavirus vaccines are at different stages of clinical trials. In India, two indigenous Covid-19 vaccines are undergoing clinical trials, including Covaxin which is being developed by Bharat Biotech and another by Zydus Cadila. India is also conducting clinical trials of the Oxford-AstraZeneca coronavirus vaccine.


If You Like This Story, Support NYOOOZ

NYOOOZ SUPPORTER

NYOOOZ FRIEND

Your support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream media organizations.


Stay updated with all the Delhi Latest News headlines here. For more exclusive & live news updates from all around India, stay connected with NYOOOZ.

Related Articles